Evidence map›Paper›PMID 23219559›Full record

ArticleAnalytical biochemistry2013

Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors.

Jun Haginaka, Tomoko Kitabatake, Iyo Hirose, Hisami Matsunaga, Ruin Moaddel

Erratum issuedAbstract read
In one paragraph

Article in Analytical biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Pharmacological Activity of Cepharanthine.Molecules (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Article
  5. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2019
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors.

Jun HaginakaSchool of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, 11-68, Nishinomiya 663-8179, Japan. haginaka@mukogawa-u.ac.jp
Tomoko Kitabatake
Iyo Hirose
Hisami Matsunaga
Ruin Moaddel

Funding

Immobilized Receptors In Drug DiscoveryZIAAG000295 · NIA · NATIONAL INSTITUTE ON AGING · PI EGAN, JOSEPHINE · 2009 to 2025
$11.4M
Intramural NIH HHS Z99 AG999999Intramural NIH HHS ZIA AG000295
6 · The paper itself

Abstract

Heat shock protein 90α (Hsp90α) immobilized on aminopropyl silica gels was prepared via the N- or C-terminal, which was termed Hsp90α-NT or Hsp90α-CT, respectively. Binding interactions of biscoclaurine alkaloids (cepharanthine (CEP), berbamine (BBM), isotetrandrine (ITD), and cycleanine (CCN)) with Hsp90α were examined using the Hsp90α-NT or -CT columns by frontal and zonal chromatography studies. The dissociation constants of CEP, BBM, ITD, and CCN to Hsp90α-NT were estimated to be 5.3, 18.6, 46.3, and 159 μM, respectively, by frontal chromatography techniques. Similar results were obtained with the Hsp90α-CT column. These data suggest that these biscoclaurine alkaloids interact with the middle domain of Hsp90α. This was confirmed by demonstrating that CEP competed with endothelial nitric oxide synthase at the middle domain of Hsp90α, where it was shown to have a dissociation constant of 15 nM. Furthermore, the Hsp90α-NT column was applied for preliminary screening of natural Hsp90α inhibitors by zonal chromatography studies.

Indexed as

Chromatography, AffinityAlkaloidsBenzodioxolesBenzylisoquinolinesHSP90 Heat-Shock ProteinsHumansImmobilized ProteinsIsoquinolinesKineticsProtein BindingRecombinant ProteinsAlkaloidsBenzodioxolesBenzylisoquinolinesberbaminecepharanthinecycleanineHSP90AA2P protein, humanHSP90 Heat-Shock ProteinsImmobilized ProteinsIsoquinolinesRecombinant Proteinstetrandrine

Identifiers

PMID23219559
PMCPMC4632246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.